HealthQuill Pharma
The European Medicines Agency has granted a marketing authorisation in the EU for Amgen Inc.’s medicine for treating thyroid eye disease, according to a statement.
Drugs Medical Pharma

Amgen’s thyroid eye disease medicine gets EU market authorisation

HQ Team April 27, 2025: The European Medicines Agency has granted a marketing authorisation in the EU for Amgen Inc.’s medicine for treating.

Read More
Johnson & Johnson’s investigational treatment to help people with a specific type of early-stage bladder cancer has shown 80% of the patients to be free of cancer for up to nine months, and 94% were able to avoid surgical removal of the organ after a year of follow-up.
Drugs Health Pharma

J&J’s trial drug for a type of bladder cancer helps avoid organ removal 

HQ Team April 27, 2025: Johnson & Johnson’s investigational treatment to help people with a specific type of early-stage bladder cancer has shown.

Read More
Uganda declared the Ebola disease outbreak, which started three months ago, has ended, according to the World Health Organization.
Drugs Health Pharma

Uganda declares Ebola disease outbreak to be over, WHO says

HQ Team April 26, 2025: Uganda declared the Ebola disease outbreak, which started three months ago, has ended, according to the World Health.

Read More
Amgen Inc. will expand its Ohio biomanufacturing facility for $900 million, after a recent move to invest $1 billion to build a second manufacturing plant in Holly Springs, North Carolina, US.
Drugs Medical Pharma

Amgen to invest $900 million in Ohio biomanufacturing facility

HQ Team April 26, 2025: Amgen Inc. will expand its Ohio biomanufacturing facility for $900 million, after a recent move to invest $1 billion to.

Read More
UNOPS stands for the United Nations Office for Project Services. It is a UN agency that implements humanitarian and development projects for the UN system, international financial institutions, and other partners. UNOPS provides infrastructure, procurement, and project management services to support peace and security, humanitarian, and development initiatives globally.
Drugs Health Pharma

UN body cuts price of medicine to combat multidrug-resistant TB

HQ Team April 23, 2025: A UN agency, the Stop TB Partnership’s Global Drug Facility (GDF), cut the price of pretomanid, a key.

Read More
Bristol Myers Squibb’s investigational oral drug for treating schizophrenia in adults failed in its main goal to treat symptoms in patients who are already on regular medication.
Drugs Health Pharma

Bristol Myers’ oral medication for schizophrenia fails to meet main goal

HQ Team April 23: Bristol Myers Squibb’s investigational oral drug for treating schizophrenia in adults failed in its main goal to treat symptoms.

Read More
Swiss healthcare multinational F. Hoffmann-La Roche AG will invest $50 billion in the US over the next five years to expand its research and manufacturing facilities.
Drugs Medical Pharma

Roche to invest $50 billion in US over next five years to expand capacity

HQ Team April 22, 2025: Swiss healthcare multinational F. Hoffmann-La Roche AG will invest $50 billion in the US over the next five.

Read More
Britain’s Medicines and Healthcare products Regulatory Agency has authorised GSK Plc’s combination drug to treat patients with multiple myeloma who have received at least one prior therapy.
Drugs Health Pharma

Britain gives green light for GSK Plc’s treatment of rare blood cancer

HQ Team April 18, 2025: Britain’s Medicines and Healthcare products Regulatory Agency has authorised GSK Plc’s combination drug to treat patients with multiple.

Read More
Sanofi S.A.’s drug, at its highest dose, has failed to meet its targeted reduction in the yearly rate of worsening episodes in adults with moderate-to-severe asthma, according to a statement.
Drugs Health Pharma

Sanofi’s test drug to treat moderate-to-severe asthma fails to meet goals 

HQ Team April 17, 2025: Sanofi S.A.’s drug, at its highest dose, has failed to meet its targeted reduction in the yearly rate.

Read More
Eisai Co., Ltd. and Biogen Inc.’s drug to treat Alzheimer’s disease got marketing authorisation in the European Union, according to a joint statement from the companies.
Drugs Health Pharma

Eisai Co, Biogen Inc.’s Alzheimer’s drug gets EU’s marketing approval

HQ Team April 16, 2025: Eisai Co., Ltd. and Biogen Inc.’s drug to treat Alzheimer’s disease got marketing authorisation in the European Union,.

Read More